Optimal Insulin Treatment in Type 2 Diabetes

被引：9
作者：
Roden, Michael [1 ,2 ]
机构：
[1] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany
[2] Heinrich Heine Univ Clin, Dept Metab Dis, Dusseldorf, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 18期
关键词：
GLUCOSE CONTROL; PARALLEL-GROUP; BASAL INSULIN; THERAPY; COMPLICATIONS; REGIMENS; GLARGINE; MELLITUS; TRIAL;
D O I：
10.1056/NEJMe0908706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1801 / 1803
页数：3
相关论文
共 17 条
  • [1] Bretzel RG, 2008, LANCET, V372, P718
  • [2] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
    Bretzel, Reinhard G.
    Nuber, Ulrike
    Landgraf, Wolfgang
    Owens, David R.
    Bradley, Clare
    Linn, Thomas
    [J]. LANCET, 2008, 371 (9618) : 1073 - 1084
  • [3] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
    Duckworth, William
    Abraira, Carlos
    Moritz, Thomas
    Reda, Domenic
    Emanuele, Nicholas
    Reaven, Peter D.
    Zieve, Franklin J.
    Marks, Jennifer
    Davis, Stephen N.
    Hayward, Rodney
    Warren, Stuart R.
    Goldman, Steven
    McCarren, Madeline
    Vitek, Mary Ellen
    Henderson, William G.
    Huang, Grant D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 129 - U62
  • [4] Effect of a multifactorial intervention on mortality in type 2 diabetes
    Gaede, Peter
    Lund-Andersen, Henrik
    Parving, Hans-Henrik
    Pedersen, Oluf
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06) : 580 - 591
  • [5] A 52-Week, Multinational, Open-Label, Parallel-Group, Noninferiority, Treat-to-Target Trial Comparing Insulin Detemir with Insulin Glargine in a Basal-Bolus Regimen with Mealtime Insulin Aspart in Patients with Type 2 Diabetes
    Hollander, Priscilla
    Cooper, John
    Bregnhoj, Jesper
    Pedersen, Claus Bang
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (11) : 1976 - 1987
  • [6] 10-year follow-up of intensive glucose control in type 2 diabetes
    Holman, Rury R.
    Paul, Sanjoy K.
    Bethel, M. Angelyn
    Matthews, David R.
    Neil, H. Andrew W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) : 1577 - 1589
  • [7] Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
    Holman, Rury R.
    Thorne, Kerensa I.
    Farmer, Andrew J.
    Davies, Melanie J.
    Keenan, Joanne F.
    Paul, Sanjoy
    Levy, Jonathan C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17) : 1716 - 1730
  • [8] Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
    Holman, Rury R.
    Farmer, Andrew J.
    Davies, Melanie J.
    Levy, Jonathan C.
    Darbyshire, Julie L.
    Keenan, Joanne F.
    Paul, Sanjoy K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18) : 1736 - 1747
  • [9] Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes
    Krssak, M
    Brehm, A
    Bernroider, E
    Anderwald, C
    Nowotny, P
    Man, CD
    Dalla Man, C
    Cline, GW
    Shulman, GI
    Waldhäusl, W
    Roden, M
    [J]. DIABETES, 2004, 53 (12) : 3048 - 3056
  • [10] Effect of glycemic exposure on the risk of microvascular complications in the diabetes trial - Revisited
    Lachin, John M.
    Genuth, Saul
    Nathan, David M.
    Zinman, Bernard
    Rutledge, Brandy N.
    [J]. DIABETES, 2008, 57 (04) : 995 - 1001
12